Target intelligence / Profile preview

Reactive oxygen species and lipid peroxidation (ROS/LPO)

Target
ROS/LPO
Molecular classification
Free radicals, Reactive metabolites, Biological process
01

Overview

Reactive oxygen species (ROS) are highly reactive oxygen-containing molecules, including superoxide and hydrogen peroxide, that serve as critical signaling molecules but cause damage when produced in excess (StatPearls, 2023). Lipid peroxidation is the specific process where ROS attack polyunsaturated fatty acids in cell membranes, initiating a self-propagating chain reaction that compromises membrane integrity (NIH, 2022). This process generates reactive aldehydes like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), which are toxic to proteins and DNA (PubMed, 2021). Pathologically, ROS and lipid peroxidation are central to ferroptosis, an iron-dependent form of regulated cell death implicated in neurodegenerative diseases like Alzheimer's and Parkinson's (Nature Reviews Molecular Cell Biology, 2020). Therapeutic interventions include radical scavengers like Edaravone and lipid-soluble antioxidants like Vitamin E, which aim to terminate the peroxidation chain (Journal of Clinical Medicine, 2021). However, drug development is complicated by the necessity of ROS for normal physiological functions, such as immune response and cell signaling, leading to potential safety concerns regarding systemic antioxidant therapy.

Other names
Oxidative stressLipid peroxidationROS-mediated damagePeroxidation of polyunsaturated fatty acids
02

Mechanism of action

Neutralization of reactive oxygen species through electron donation, inhibition of the lipid radical chain reaction, and sequestration of catalytic metal ions to prevent hydroxyl radical formation.

03

Biological functions

Cell signalingHomeostasisFerroptosisOxidative damageApoptosis
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerInflammationIschemia-reperfusion injury
05

Safety considerations

Interference with physiological redox signalingPotential pro-oxidant effects at high dosesPoor bioavailability and metabolic stability of many antioxidants
06

Interacting drugs

Edaravone

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-Isoprostane8-Oxo-2'-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Reactive oxygen species and lipid peroxidation (ROS/LPO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and lipid peroxidation (ROS/LPO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call